GILD

Gilead Sciences, Inc. News Headlines

$111.54
*  
2.68
2.35%
Get GILD Alerts
*Delayed - data as of Oct. 31, 2014 15:19 ET  -  Find a broker to begin trading GILD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    GILD Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Gilead: Still 40% Upside Ahead
10/31/2014 11:43:00 AM - Seeking Alpha


Did Gilead Sciences Really Disappoint With Its Earnings Announcement?
10/31/2014 8:14:00 AM - Seeking Alpha


Jim Cramer's Top Stock Picks: CELG REGN GILD BIIB TTWO CRL FLEX
10/31/2014 6:00:00 AM - TheStreet


Cramer's Mad Money - Charles River Labs Battles Ebola (10/30/14)
10/31/2014 5:46:00 AM - Seeking Alpha


5 Things McKesson Corporation's Management Wants You to Know
10/30/2014 6:23:34 PM - Motley Fool


Netflix and Gilead Will See More Gains, Says Thornburg Value Manager
10/30/2014 5:54:00 PM - TheStreet


Third Quarter Earnings Season Halftime Report
10/30/2014 3:05:00 PM - Seeking Alpha


5 Things Bristol-Myers Squibb Co.'s Management Wants You to Know
10/30/2014 11:18:31 AM - Motley Fool


Update: Gilead Q3 Earnings - Sovaldi Sales Are Down
10/30/2014 10:13:00 AM - Seeking Alpha


Update: Gilead's Impressive Earnings Confirm Our Bull Case
10/30/2014 10:11:00 AM - Seeking Alpha


Gilead Sciences: Another Solid Quarter, Long Term Appeal Remains
10/30/2014 10:04:00 AM - Seeking Alpha


Amgen Continues To Offer The Best Value In Biotech
10/30/2014 9:23:00 AM - Seeking Alpha


Why You Shouldn't Worry About Gilead Sciences, Inc.
10/30/2014 8:10:02 AM - Motley Fool


Gilead Sciences: Even More Attractive After Third Quarter Results
10/30/2014 8:08:00 AM - Seeking Alpha


Amgen’s operating margins have been flat despite revenue growth
10/29/2014 5:00:00 PM - Market Realist


Optimize Your Dividend Growth Portfolio
10/29/2014 2:52:00 PM - Seeking Alpha


Gilead: Buy the Dip -- Barron's
10/29/2014 2:45:00 PM - Dow Jones Business News


Cramer: Don't Sell U.S. Steel or Gilead Sciences on Earnings
10/29/2014 10:53:00 AM - TheStreet


Gilead Sciences (GILD) Stock Declines After Weak Third-Quarter Results
10/29/2014 10:37:00 AM - TheStreet


Third Point Partners ups stake in Amgen
10/29/2014 9:00:00 AM - Market Realist


Gilead Beats on Q3 Earnings, Sovaldi Sales Fall Sequentially - Analyst Blog
10/29/2014 9:00:00 AM - Zacks.com


In the news: Facebook earnings, AT&T facing a lawsuit over throttling and more
10/29/2014 8:45:00 AM - Market Intelligence Center


Gilead (GILD) Posts Weak Earnings; Stock Falls 4% After-Hours - Stocks in the News
10/28/2014 11:58:12 PM - Zacks.com


Gilead Sciences Q3 Profit More Than Triples, Results Top View
10/28/2014 11:13:00 PM - RTT News


What to Make of Gilead Sciences Inc.'s Third-Quarter Earnings Miss
10/28/2014 6:48:21 PM - Motley Fool